National Health Investors (NHI) Liabilities and Shareholders Equity (2009 - 2026)

National Health Investors has reported Liabilities and Shareholders Equity for 18 years, with the latest figure at $2.9 billion in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 3.84% year-over-year to $2.9 billion; the trailing twelve-month figure through Mar 2026 stood at $11.1 billion (up 7.15% YoY), and the FY2025 full-year result was $2.8 billion, up 6.98% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $2.9 billion, up from $2.8 billion in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $2.9 billion in Q1 2026, with the low at $2.5 billion in Q3 2024.
• Historically, Liabilities and Shareholders Equity has averaged $2.6 billion across 5 years, with a median of $2.5 billion in 2023.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity fell 15.93% — and 2025, when it rose 12.3%.
• National Health Investors' Liabilities and Shareholders Equity stood at $2.5 billion in 2022, then decreased by 0.76% to $2.5 billion in 2023, then advanced by 5.06% to $2.6 billion in 2024, then rose by 6.98% to $2.8 billion in 2025, then climbed by 3.32% to $2.9 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $2.9 billion (Q1 2026), $2.8 billion (Q4 2025), and $2.7 billion (Q3 2025), per Business Quant data.